NO984445L - Tetrahydro-<beta>-karbolinforbindelser - Google Patents

Tetrahydro-<beta>-karbolinforbindelser

Info

Publication number
NO984445L
NO984445L NO984445A NO984445A NO984445L NO 984445 L NO984445 L NO 984445L NO 984445 A NO984445 A NO 984445A NO 984445 A NO984445 A NO 984445A NO 984445 L NO984445 L NO 984445L
Authority
NO
Norway
Prior art keywords
beta
tetrahydro
karbolinforbindelser
compounds
carboline
Prior art date
Application number
NO984445A
Other languages
English (en)
Norwegian (no)
Other versions
NO984445D0 (no
Inventor
James E Audia
David L G Nelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984445D0 publication Critical patent/NO984445D0/no
Publication of NO984445L publication Critical patent/NO984445L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO984445A 1996-03-25 1998-09-24 Tetrahydro-<beta>-karbolinforbindelser NO984445L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1411996P 1996-03-25 1996-03-25
PCT/US1997/004473 WO1997035578A1 (en) 1996-03-25 1997-03-24 Tetrahydro-beta-carboline compounds

Publications (2)

Publication Number Publication Date
NO984445D0 NO984445D0 (no) 1998-09-24
NO984445L true NO984445L (no) 1998-11-20

Family

ID=21763645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984445A NO984445L (no) 1996-03-25 1998-09-24 Tetrahydro-<beta>-karbolinforbindelser

Country Status (20)

Country Link
US (1) US5886004A (de)
EP (1) EP0942722B1 (de)
JP (1) JP2001509130A (de)
KR (1) KR20000004963A (de)
CN (1) CN1225584A (de)
AT (1) ATE267012T1 (de)
AU (1) AU714024B2 (de)
BR (1) BR9708347A (de)
CA (1) CA2248874A1 (de)
CZ (1) CZ298098A3 (de)
DE (1) DE69729211T2 (de)
EA (1) EA199800867A1 (de)
ES (1) ES2221049T3 (de)
IL (1) IL126062A0 (de)
NO (1) NO984445L (de)
NZ (1) NZ331827A (de)
PL (1) PL329212A1 (de)
TR (1) TR199801910T2 (de)
WO (1) WO1997035578A1 (de)
YU (1) YU41998A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
WO2000069437A1 (en) 1999-05-18 2000-11-23 Synaptic Pharmaceutical Corporation Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
US6444477B1 (en) * 2000-11-28 2002-09-03 Pharmagene Laboratories Limited Assay method for detecting 5-HT2B antagonists
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
EP1716867A4 (de) * 2004-02-20 2009-09-23 Astellas Pharma Inc Mittel zur prävention von migräne
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
MX2007008434A (es) * 2005-01-19 2007-07-25 Squibb Bristol Myers Co Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos.
WO2006085510A1 (ja) * 2005-02-08 2006-08-17 Astellas Pharma Inc. 過敏性腸症候群の治療薬
DE602006017694D1 (de) * 2005-06-27 2010-12-02 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
AU2006261828A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP1896417B1 (de) 2005-06-27 2011-03-23 Bristol-Myers Squibb Company Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
WO2007002634A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
CA2617473A1 (en) * 2005-08-08 2007-02-15 Astellas Pharma Inc. Acylguanidine derivative or salt thereof
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2012051502A1 (en) 2010-10-14 2012-04-19 University Of Utah Research Foundation Methods and compositions related to neuroactive thiazoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500431A (en) * 1993-04-14 1996-03-19 Eli Lilly And Company Tetrahydro-β-carbolines
CA2185236A1 (en) * 1994-03-11 1995-09-14 James Edmund Audia Method for treating 5ht2b receptor related conditions
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
JP2000507269A (ja) * 1996-03-15 2000-06-13 イーライ・リリー・アンド・カンパニー 一般かぜまたはアレルギー性鼻炎の処置方法
US5886003A (en) * 1996-03-25 1999-03-23 Eli Lilly And Company Methods of treating or ameliorating the symptoms of venomous bites and stings

Also Published As

Publication number Publication date
EP0942722A4 (de) 2002-06-05
US5886004A (en) 1999-03-23
CN1225584A (zh) 1999-08-11
DE69729211D1 (en) 2004-06-24
AU714024B2 (en) 1999-12-16
PL329212A1 (en) 1999-03-15
DE69729211T2 (de) 2005-05-04
EA199800867A1 (ru) 1999-02-25
IL126062A0 (en) 1999-05-09
EP0942722B1 (de) 2004-05-19
KR20000004963A (ko) 2000-01-25
BR9708347A (pt) 1999-08-03
ES2221049T3 (es) 2004-12-16
NZ331827A (en) 2000-02-28
TR199801910T2 (xx) 1998-12-21
WO1997035578A1 (en) 1997-10-02
JP2001509130A (ja) 2001-07-10
ATE267012T1 (de) 2004-06-15
NO984445D0 (no) 1998-09-24
CZ298098A3 (cs) 1999-02-17
YU41998A (sh) 1999-07-28
CA2248874A1 (en) 1997-10-02
AU2536197A (en) 1997-10-17
EP0942722A1 (de) 1999-09-22

Similar Documents

Publication Publication Date Title
NO984445L (no) Tetrahydro-&lt;beta&gt;-karbolinforbindelser
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
DK0918774T3 (da) Androgenreceptormodulatorforbindelser og fremgangsmåder
AU3075184A (en) Leukotriene antagonists
CO4290416A1 (es) Antagonistas de receptores de taquicinas no-peptidos
ATE245993T1 (de) Allosterische modulatoren des nmda-rezeptors
DK0800519T3 (da) Steroidreceptormodulatorforbindelser og fremgangsmåder
AP9801269A0 (en) Prostaglandin agonists.
NO975975L (no) Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
AU1582197A (en) Combinatorial process for preparing substituted indane libraries
DK0852587T3 (da) Syntetiske peptider der inhiberer IL-6-aktivitet
BR9711477A (pt) Derivado de benzocicloheptapiridina substituida Úteis para inibi-Æo de transferase de farnesila
BR9712980A (pt) Compostos úteis para inibição de transferase de proteina de farnesila
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
FI905957A (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
PL331942A1 (en) Method of biologically transforming colchicinoid compounds into their correcponding 3-glycoside derivatives
NO943765L (no) Aryloksybenzen-herbicidmidler
DK0900218T3 (da) Heterocykliske forbindelser
MX9207264A (es) Compuestos de sulfonimidamida, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
ATE204847T1 (de) Tetracyclische aromatische retinoide verbindungen,ihre herstellung und verwendung
UA39903C2 (uk) Спосіб виділення фактора росту нервової тканини з отрути гюрзи